Login to Your Account



Alternatives to FDA regulation of lab tests pepper Senate hearing

By Mark McCarty
Regulatory Editor

Tuesday, September 20, 2016

A Senate hearing on clinical lab testing and its impact on precision medicine included the usual array of concerns about the potential for FDA regulation of lab-developed tests to impede precision medicine.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription